Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Multiple Doses of Fluticasone Propionate in Healthy Subjects

Trial Profile

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Multiple Doses of Fluticasone Propionate in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs Ketorolac (Primary) ; Fluticasone propionate
  • Indications Acute pain; Allergic rhinitis; Asthma; Migraine
  • Focus Pharmacokinetics
  • Sponsors Luitpold Pharmaceuticals
  • Most Recent Events

    • 08 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top